michigan semaglutide gastric stasis lawsuit glp-1 in American Society for Gastrointestinal Endoscopy position statement on periendoscopic Wegovy Lawsuit [2026 Update] |

Celebrities have touted their use of it

Faghris work includes the application of cognitive-behavioral techniques and social support to improve self-regulation, enhance self-efficacy, and increase self-control

Consequently, the higher dose of semaglutide gives Wegovy a slight advantage over Ozempic when considering its effectiveness

Thats not where the risk-benefit lies. Given that health insurance wont cover GLP-1s if you arent obese, dont have type 2 diabetes, or arent overweight with cardiovascular disease, the cost can add up for years before you know whether the spend was really worth it

Ozempic (semaglutide) was primarily approved for the treatment of type 2 diabetes and not specifically for weight loss, although weight loss is often a beneficial side effect for many individuals using Ozempic for diabetes management